209 related articles for article (PubMed ID: 8912871)
41. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
42. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.
Li T; Yang W; Li M; Byun DS; Tong C; Nasser S; Zhuang M; Arango D; Mariadason JM; Augenlicht LH
Mol Nutr Food Res; 2008 Nov; 52(11):1289-99. PubMed ID: 18435490
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
44. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
45. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
Carter JH; Deddens JA; Pullman JL; Colligan BM; Whiteley LO; Carter HW
Clin Cancer Res; 1997 Sep; 3(9):1479-89. PubMed ID: 9815834
[TBL] [Abstract][Full Text] [Related]
46. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
Forslund A; Engarås B; Lönnroth C; Lundholm K
Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
[TBL] [Abstract][Full Text] [Related]
47. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
48. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
[TBL] [Abstract][Full Text] [Related]
49. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
50. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Gebauer G; Müller-Ruchholtz W
Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569
[TBL] [Abstract][Full Text] [Related]
51. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
52. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
[TBL] [Abstract][Full Text] [Related]
53. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
54. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.
Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM
Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170
[TBL] [Abstract][Full Text] [Related]
55. [Serum sialyl-Tn antigen in colorectal cancer and its relationship to prognosis].
Yamaguchi A; Tukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1992 Mar; 19(3):349-53. PubMed ID: 1543361
[TBL] [Abstract][Full Text] [Related]
56. Circulating vascular endothelial growth factor in patients with colorectal cancer.
Fujisaki K; Mitsuyama K; Toyonaga A; Matsuo K; Tanikawa K
Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253
[TBL] [Abstract][Full Text] [Related]
57. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
58. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
59. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
Sun G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818
[TBL] [Abstract][Full Text] [Related]
60. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]